Your browser doesn't support javascript.
Weight loss for cardiovascular disease prevention - is semaglutide the answer?
Lavie, Carl J; Bhatt, Deepak L; Neeland, Ian J; Heymsfield, Steven B.
  • Lavie CJ; John Ochsner Heart and Vascular Institute, Ochsner Clinical School-the University of Queensland School of Medicine, 1514 Jefferson Highway, New Orleans, LA 70121-2483, USA. Electronic address: clavie@ochsner.org.
  • Bhatt DL; Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, MA, USA.
  • Neeland IJ; UH Center for Cardiovascular Prevention and Center for Integrated, and Novel Approaches in Vascular-Metabolic Disease (CINEMA), Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland OH, USA.
  • Heymsfield SB; Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA, USA.
Trends Cardiovasc Med ; 2022 Jan 05.
Article in English | MEDLINE | ID: covidwho-2324340
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal subject: Vascular Diseases / Cardiology Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal subject: Vascular Diseases / Cardiology Year: 2022 Document Type: Article